Stable liposomal formulations for ocular drug delivery
Abstract:
A stable liposomal formulation for ocular delivery. The formulation contains a liposome that includes at least one lipid bilayer containing a phosphatidylcholine, and a prostaglandin F2α encapsulated in the liposome. Also provided is a method for treating an ocular disorder with the formulation.
Public/Granted literature
Information query
Patent Agency Ranking
0/0